Techne Up 2.2 percent Since Last Earnings Report Can It Continue?
TECH Stock | USD 73.89 2.00 2.64% |
Under 66% of Bio Techne's investor base is looking to short. The analysis of overall sentiment of trading Bio Techne Corp stock suggests that many investors are alarmed at this time. Bio Techne's investing sentiment shows overall attitude of investors towards Bio Techne Corp.
Bio |
Techne reported earnings 30 days ago. Whats next for the stock We take a look at earnings estimates for some clues.
Read at zacks.com
Bio Techne Corp Current Investor Sentiment
Panic Vs Confidence
34
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Bio Techne's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Bio Techne Corp.
News SentimentBearish | Hype SentimentBearish | Insider SentimentWaiting |
Bio Techne Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Bio Techne can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Bio Techne Corp Historical Investor Sentiment
Investor biases related to Bio Techne's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Techne Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bio Techne's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bio Techne and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bio Techne news discussions. The higher the estimate score, the more favorable the investor's outlook on Bio Techne.
Bio Techne Fundamental Analysis
We analyze Bio Techne's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Techne using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Bio Techne is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Bio Techne Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Techne stock to make a market-neutral strategy. Peer analysis of Bio Techne could also be used in its relative valuation, which is a method of valuing Bio Techne by comparing valuation metrics with similar companies.
Peers
Bio Techne Related Equities
LQDA | Liquidia Technologies | 3.52 | ||||
BGNE | BeiGene | 1.29 | ||||
ASND | Ascendis Pharma | 0.81 | ||||
EXEL | Exelixis | 0.75 | ||||
TVTX | Travere Therapeutics | 0.21 | ||||
UTHR | United Therapeutics | 0.01 | ||||
NUVL | Nuvalent | 0.52 | ||||
BMRN | Biomarin Pharmaceutical | 0.53 | ||||
REPL | Replimune | 0.91 | ||||
HALO | Halozyme Therapeutics | 1.13 | ||||
ALNY | Alnylam Pharmaceuticals | 1.14 | ||||
BPMC | Blueprint Medicines | 1.49 | ||||
LEGN | Legend Biotech | 1.86 | ||||
APLS | Apellis Pharmaceuticals | 1.99 | ||||
PCVX | Vaxcyte | 3.22 | ||||
VTYX | Ventyx Biosciences | 3.46 | ||||
AKRO | Akero Therapeutics | 3.95 |
Complementary Tools for Bio Stock analysis
When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |